David Windley Recent News
Jefferies Downgrades ICON To Hold, Cites Lower Bookings, Sales
Looking Past M&A: The Best Managed Care Stock Plays For The Long Haul
How The Street Is Reacting To The Aetna-Humana Deal
Jefferies Boosts Targets Across Pharmaceutical Service Stocks
UPDATE: Jefferies Reiterates On Humana Inc As Management Displays Confidence
Jefferies Analyst Names Favorites In Managed Healthcare Sector
UPDATE: Jefferies Raises PT on WuXi PharmaTech Following Raised 2013 EPS Guidance
UPDATE: Jefferies Raises PT on PAREXEL Following Solid 2Q Results
UPDATE: Jefferies Raises PT on WellCare Health Plans Following Stock Surge
UPDATE: Jefferies Raises PT on UnitedHealth Group Ahead of 2Q Earnings Report
UPDATE: Jefferies Raises PT on Humana Ahead of 2Q Earnings Report
UPDATE: Jefferies Raises PT on Cigna Ahead of 2Q Earnings Report
UPDATE: Jefferies Raises PT on Aetna Ahead of 2Q Earnings Report
UPDATE: Jefferies Raises PT on WellPoint Ahead of 2Q Earnings Report
UPDATE: Jefferies Raises PT on PAREXEL on Tough Margin Outlook, Premium Valuation
UPDATE: Jefferies Raises PT on Centene Following Exit Delay Announcement
UPDATE: Jefferies Initiates Quintiles Transnational at Hold on Valuation
UPDATE: Jefferies Raises PT on Aetna Following Coventry Acquisition
Jefferies Rates Pharmaceutical Product Development ( PPDI) A Buy
Jefferies & Company, Inc. Upgrades Warner Chilcott Ltd. (WCRX) To Buy Rating
ICON (ICLR) Maintains A Buy Rating